{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:06:39Z","timestamp":1787695599847,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Minnesota School of Nursing Foundation"},{"name":"Pine Tree Apple Classic Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11764-025-01763-y","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:05:26Z","timestamp":1740103526000},"page":"1631-1647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of chemotherapy-induced peripheral neuropathy on physical function in pediatric cancer survivors: a systematic review"],"prefix":"10.1007","volume":"20","author":[{"given":"Lynn R.","family":"Tanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Demers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica N.","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan S.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Hooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie M.","family":"Turcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Treat-Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"publisher","unstructured":"Gilchrist LS, Tanner L. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2013;. https:\/\/doi.org\/10.1007\/s00520-012-1591-8","DOI":"10.1007\/s00520-012-1591-8"},{"key":"1763_CR2","doi-asserted-by":"publisher","unstructured":"Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst. 2009;. https:\/\/doi.org\/10.1111\/j.1529-8027.2009.00230.x","DOI":"10.1111\/j.1529-8027.2009.00230.x"},{"key":"1763_CR3","doi-asserted-by":"publisher","unstructured":"Bjornard KL, Gilchrist LS, Inaba H, et al. Peripheral neuropathy in children and adolescents treated for cancer. Lancet Child Adolesc Health. 2018;. https:\/\/doi.org\/10.1016\/S2352-4642(18)30236-0","DOI":"10.1016\/S2352-4642(18)30236-0"},{"key":"1763_CR4","doi-asserted-by":"publisher","unstructured":"Knoerl R, Gilchrist L, Kanzawa-Lee GA, Donohoe C, Bridges C, Lavoie Smith EM. Proactive rehabilitation for chemotherapy-induced peripheral neuropathy. Semin Oncol Nurs. 2020;. https:\/\/doi.org\/10.1016\/j.soncn.2019.150983","DOI":"10.1016\/j.soncn.2019.150983"},{"key":"1763_CR5","doi-asserted-by":"publisher","unstructured":"Lavoie Smith EM, Li L, Chiang C, et al. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Peripher Nerv Syst. 2015;. https:\/\/doi.org\/10.1111\/jns.12114","DOI":"10.1111\/jns.12114"},{"key":"1763_CR6","doi-asserted-by":"publisher","unstructured":"Ness KK, Hudson MM, Pui CH, et al. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer. 2012;. https:\/\/doi.org\/10.1002\/cncr.26337","DOI":"10.1002\/cncr.26337"},{"key":"1763_CR7","doi-asserted-by":"publisher","unstructured":"G\u00f6tte M, Kesting SV, Winter CC, Rosenbaum D, Boos J. Motor performance in children and adolescents with cancer at the end of acute treatment phase. Eur J Pediatr. 2015;. https:\/\/doi.org\/10.1007\/s00431-014-2460-x","DOI":"10.1007\/s00431-014-2460-x"},{"key":"1763_CR8","doi-asserted-by":"publisher","unstructured":"S\u00f6ntgerath R, Eckert K. Impairments of lower extremity muscle strength and balance in childhood cancer patients and survivors: a systematic review. Pediatr Hematol Oncol. 2015;. https:\/\/doi.org\/10.3109\/08880018.2015.1079756","DOI":"10.3109\/08880018.2015.1079756"},{"key":"1763_CR9","doi-asserted-by":"publisher","unstructured":"Tanner L, Sencer S, Hooke MC. The Stoplight Program: a proactive physical therapy intervention for children with acute lymphoblastic leukemia. J Pediatr Oncol Nurs. 2017;. https:\/\/doi.org\/10.1177\/1043454217698093","DOI":"10.1177\/1043454217698093"},{"key":"1763_CR10","doi-asserted-by":"publisher","unstructured":"Beulertz J, Bloch W, Prokop A, et al. Limitations in ankle dorsiflexion range of motion, gait, and walking efficiency in childhood cancer survivors. Cancer Nurs. 2016;. https:\/\/doi.org\/10.1097\/NCC.0000000000000256","DOI":"10.1097\/NCC.0000000000000256"},{"key":"1763_CR11","doi-asserted-by":"publisher","unstructured":"Ehrhardt MJ, Sandlund JT, Zhang N, et al. Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: a report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2017;. https:\/\/doi.org\/10.1002\/pbc.26338","DOI":"10.1002\/pbc.26338"},{"key":"1763_CR12","doi-asserted-by":"publisher","unstructured":"Webster RT, Dhaduk R, Gordon ML, et al. Health behavior profiles in young survivors of childhood cancer: findings from the St. Jude Lifetime Cohort Study. Cancer. 2023;. https:\/\/doi.org\/10.1002\/cncr.34749","DOI":"10.1002\/cncr.34749"},{"key":"1763_CR13","doi-asserted-by":"publisher","unstructured":"Ness KK, DeLany JP, Kaste SC, et al. Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia. Blood. 2015;. https:\/\/doi.org\/10.1182\/blood-2015-01-621680","DOI":"10.1182\/blood-2015-01-621680"},{"key":"1763_CR14","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"1763_CR15","unstructured":"World Health Organization. International classification of functioning, disability and health : ICF. World Health Organization. 2001. https:\/\/iris.who.int\/handle\/10665\/42407 Accessed 01 March 2024"},{"key":"1763_CR16","doi-asserted-by":"publisher","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","DOI":"10.1186\/s13643-016-0384-4"},{"key":"1763_CR17","unstructured":"VERBI Software. MAXQDA 2022 [computer software]. Berlin, Germany: VERBI Software. 2021. Available from maxqda.com."},{"key":"1763_CR18","unstructured":"Microsoft, C., Microsoft 365 Excel. 2022, Microsoft Corporation. https:\/\/www.microsoft.com\/en-us\/microsoft-365\/excel"},{"key":"1763_CR19","doi-asserted-by":"publisher","unstructured":"Tufanaru C, M.Z., Aromataris E, Campbell J, Hopp L. Chapter 3: systematic reviews of effectiveness. In: Aromataris E, Munn Z (Editors). JBI manual for evidence synthesis. JBI, 2020;. https:\/\/doi.org\/10.46658\/JBIRM-17-03","DOI":"10.46658\/JBIRM-17-03"},{"key":"1763_CR20","doi-asserted-by":"publisher","unstructured":"van de Velde ME, van den Berg MH, Kaspers GJL, et al. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer. Cancer Med. 2021;. https:\/\/doi.org\/10.1002\/cam4.4289","DOI":"10.1002\/cam4.4289"},{"key":"1763_CR21","doi-asserted-by":"publisher","unstructured":"Kandula T, Farrar MA, Cohn RJ, et al. Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes. JAMA Neurol, 2018;. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0963","DOI":"10.1001\/jamaneurol.2018.0963"},{"key":"1763_CR22","doi-asserted-by":"publisher","unstructured":"Sands S, Ladas EJ, Kelly KM, et al. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Support Cancer Care, 2017;. https:\/\/doi.org\/10.1007\/s00520-016-3441-6","DOI":"10.1007\/s00520-016-3441-6"},{"key":"1763_CR23","doi-asserted-by":"publisher","unstructured":"Gilchrist LS, Tanner LR. Short-term recovery of balance control: association with chemotherapy-induced peripheral neuropathy in pediatric oncology. Pediatr Phys Ther. 2018;. https:\/\/doi.org\/10.1097\/PEP.0000000000000484","DOI":"10.1097\/PEP.0000000000000484"},{"key":"1763_CR24","doi-asserted-by":"publisher","unstructured":"Gilchrist L, Tanner L. Gait patterns in children with cancer and vincristine neuropathy. Pediatr Phys Ther. 2016;. https:\/\/doi.org\/10.1097\/PEP.0000000000000208","DOI":"10.1097\/PEP.0000000000000208"},{"key":"1763_CR25","doi-asserted-by":"publisher","unstructured":"Li T, Kandula T, Cohn RJ, Kiernan MC, Park SB, Farrar MA. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia. Clin Neurophysiol. 2023;. https:\/\/doi.org\/10.1016\/j.clinph.2023.08.002","DOI":"10.1016\/j.clinph.2023.08.002"},{"key":"1763_CR26","doi-asserted-by":"publisher","unstructured":"Rodwin RL, Kairalla JA, Hibbitts E, et al. Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood b-acute lymphoblastic leukemia. J Natl Cancer Inst. 2022;. https:\/\/doi.org\/10.1093\/jnci\/djac095","DOI":"10.1093\/jnci\/djac095"},{"key":"1763_CR27","doi-asserted-by":"publisher","unstructured":"Rodwin RL, DelRocco NJ, Hibbitts E, et al. Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia. Pediatr Blood Cancer. 2023;. https:\/\/doi.org\/10.1002\/pbc.30634","DOI":"10.1002\/pbc.30634"},{"key":"1763_CR28","doi-asserted-by":"publisher","unstructured":"Singhal N, Samuel SR, Kumar VK, Prasad H, Saraswathy MV. Evaluation of chemotherapy induced peripheral neuropathy, sarcopenia and fatigue in children with acute lymphoblastic leukaemia and lymphoma in tertiary care hospital, Dakshina Kannada. Indian J Palliat Care. 2023;. https:\/\/doi.org\/10.25259\/IJPC_143_2023","DOI":"10.25259\/IJPC_143_2023"},{"key":"1763_CR29","doi-asserted-by":"publisher","unstructured":"Smith EML, Kuisell C, Kanzawa-Lee G, et al. Assessment of pediatric chemotherapy-induced peripheral neuropathy using a new patient-reported outcome measure: the P-CIN.\u00a0J Pediatr Oncol Nurs. 2021;. https:\/\/doi.org\/10.1177\/1043454220980253","DOI":"10.1177\/1043454220980253"},{"key":"1763_CR30","doi-asserted-by":"publisher","unstructured":"Wright MJ, Twose DM, Gorter JW. Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia. Gait Posture. 2017;. https:\/\/doi.org\/10.1016\/j.gaitpost.2017.05.004","DOI":"10.1016\/j.gaitpost.2017.05.004"},{"key":"1763_CR31","doi-asserted-by":"publisher","unstructured":"Wright M, Twose D, Gorter JW. Multidimensional outcome measurement of children and youth with neuropathy following treatment of leukemia: cross-sectional descriptive report. Rehabil Oncol, 2019;. https:\/\/doi.org\/10.1097\/01.REO.0000000000000152","DOI":"10.1097\/01.REO.0000000000000152"},{"key":"1763_CR32","doi-asserted-by":"publisher","unstructured":"Tay CG, Lee VWM, Ong LC, Goh KJ, Ariffin H, Fong CY. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2017;. https:\/\/doi.org\/10.1002\/pbc.26471","DOI":"10.1002\/pbc.26471"},{"key":"1763_CR33","unstructured":"National Cancer Institute of the National Institutes of Health. Common Terminology Criteria for Adverse Events v.5.0. 2017. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60. Accessed 10 Oct 2024."},{"key":"1763_CR34","doi-asserted-by":"publisher","unstructured":"Wright MJ, Fairfield SM. Adaptation and psychometric properties of the gross motor function measure for children receiving treatment for acute lymphoblastic leukemia. Rehabil Oncol, 2007;. https:\/\/doi.org\/10.1097\/01893697-200725040-00003","DOI":"10.1097\/01893697-200725040-00003"},{"key":"1763_CR35","doi-asserted-by":"publisher","unstructured":"Bruininks RH, Bruininks BD. Bruininks-Oseretsky Test of motor proficiency, Second Edition (BOT-2) APA PsycTests. 2005;. https:\/\/doi.org\/10.1037\/t14991-000","DOI":"10.1037\/t14991-000"},{"key":"1763_CR36","doi-asserted-by":"publisher","unstructured":"Mancini V, Rudaizky D, Howlett S, Elizabeth-Price J, Chen W. Movement difficulties in children with ADHD: comparing the long- and short-form Bruininks-Oseretsky Test of Motor Proficiency-Second Edition (BOT-2). Aust Occup Ther J. 2020;. https:\/\/doi.org\/10.1111\/1440-1630.12641","DOI":"10.1111\/1440-1630.12641"},{"key":"1763_CR37","doi-asserted-by":"publisher","unstructured":"Yeh KK, Liu WY, Yang ML, Liu CH, Lien HY, Chung CY. Sufficiency of the BOT-2 Short Form to screen motor competency in preschool children with strabismus. PLoS One. 2021;. https:\/\/doi.org\/10.1371\/journal.pone.0261549","DOI":"10.1371\/journal.pone.0261549"},{"key":"1763_CR38","doi-asserted-by":"publisher","unstructured":"Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;. https:\/\/doi.org\/10.1007\/s00520-014-2255-7","DOI":"10.1007\/s00520-014-2255-7"},{"key":"1763_CR39","doi-asserted-by":"publisher","unstructured":"Wechsler S, Wood L. The effect of chemotherapy on balance, gait, and falls among cancer survivors: a scoping review. Rehabil Oncol., 2021;. https:\/\/doi.org\/10.1097\/01.REO.0000000000000238","DOI":"10.1097\/01.REO.0000000000000238"},{"key":"1763_CR40","doi-asserted-by":"publisher","unstructured":"Chung KH, Park SB, Streckmann F, et al. Mechanisms, mediators, and moderators of the effects of exercise on chemotherapy-induced peripheral neuropathy. Cancers (Basel). 2022;. https:\/\/doi.org\/10.3390\/cancers14051224","DOI":"10.3390\/cancers14051224"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-025-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-025-01763-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-025-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:13:56Z","timestamp":1784189636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-025-01763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s11764-025-01763-y","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LRT is the CEO\/Founder of a digital health company.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}